Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds UBS Upgrades Universal Health Services to Neutral, Raises Price Target to $167

UBS Upgrades Universal Health Services to Neutral, Raises Price Target to $167

UBS analyst Andrew Mok upgrades Universal Health Services (NYSE:UHS) from Sell to Neutral and raises the price target from $113 to $167.

byBenzinga Newsdesk

January 24, 2023

1 minute read

UBS analyst Andrew Mok upgrades Universal Health Services (NYSE:UHS) from Sell to Neutral and raises the price target from $113 to $167.

Analyst Ratings

9 Analysts Have This to Say About R1 RCM

By Benzinga Insights

December 5, 3:01 PM

Over the past 3 months, 9 analysts have published their opinion on R1 RCM (NASDAQ:RCM) stock. These analysts…

RCM

Analyst Ratings

RBC Capital Maintains Outperform Rating for FirstService: Here’s What You Need To Know

By Benzinga Insights

December 20, 1:00 PM

RBC Capital has decided to maintain its Outperform rating of FirstService (NASDAQ:FSV) and raise its price target from…

FSV

Farmmi Wins New Export Order For Israel

By Shivani Kumaresan

September 20, 9:12 AM

Farmmi Inc (NASDAQ:FAMI) has bagged a new sales order for its dried Shiitake mushrooms and black fungus. The latest multi-product order…

FAMI

Medical Cannabis Industry In Africa: Projected 20.12% CAGR Surge By 2028, Reveals New Report

By Joana Scopel

August 24, 2:57 PM

IMARC Group's new report delves into the dynamic landscape of medical cannabis in Africa, shedding light on key trends, growth drivers and major players shaping the industry.

AGEEF

UBS Upgrades Universal Health Services to Neutral, Raises Price Target to $167

Related Posts

9 Analysts Have This to Say About R1 RCM

RBC Capital Maintains Outperform Rating for FirstService: Here’s What You Need To Know

Farmmi Wins New Export Order For Israel

Medical Cannabis Industry In Africa: Projected 20.12% CAGR Surge By 2028, Reveals New Report